D. Ackermann
Founder bei Presidio Medical, Inc.
Profil
D.
Michael Ackermann is the founder of Tangible Science, Inc. (founded in 2011).
He was also the founder of Oculeve, Inc. (founded in 2012) where he held the title of President & Chief Executive Officer from 2012 to 2015.
Additionally, he was the founder of Oyster Point Pharma, Inc. (founded in 2015) where he served as Chairman from 2017 to 2020.
He was also the founder of Tarsus Pharmaceuticals, Inc. (founded in 2017) where he was Chairman from 2017 to 2022.
Furthermore, he is the founder of Presidio Medical, Inc. (founded in 2017) and currently holds the position of Director since 2021.
Dr. Ackermann's current job(s) include being the Director-Biotechnology at Stanford Byers Center for Biodesign and an Advisor at Vensana Capital Management LLC since 2019.
His former job includes working at Allergan, Inc. as Vice President-Neurostimulation from 2015 to 2017.
Dr. Ackermann's education history includes an undergraduate degree from Vanderbilt University and graduate and doctorate degrees from Case Western Reserve University.
Aktive Positionen von D. Ackermann
Unternehmen | Position | Beginn |
---|---|---|
Presidio Medical, Inc.
Presidio Medical, Inc. Medical SpecialtiesHealth Technology Presidio Medical, Inc. operates as a bioelectronic medicine firm. It develops fundamental neuromodulation platform to establish a new class of therapeutic medical devices. The company was founded by Kenneth Wu on November 14, 2018 and is headquartered in Carson City, NV. | Founder | 01.09.2017 |
Stanford Byers Center for Biodesign
Stanford Byers Center for Biodesign Miscellaneous Commercial ServicesCommercial Services Stanford Byers Center for Biodesign is a private company committed to advancing health outcomes and equity through innovation education, translation, and policy. More than 4.3 million people have been helped by technologies invented at Stanford Biodesign, and the biodesign innovation process has been widely adopted by universities and training programs around the world. The American company believes that diversity across multiple dimensions inspires creativity and helps them innovate for all patient populations. The company was founded by Joshua Makower and Paul G. Yock in 2001 at Stanford. | Corporate Officer/Principal | - |
Vensana Capital Management LLC
Vensana Capital Management LLC Investment ManagersFinance Vensana Capital Management LLC (Vensana Capital) is a venture capital and growth equity investment firm founded in 2019 by Peter Klein Justin & Kirk G. Nielsen. The firm is headquartered in Saint Paul, Minnesota. | Consultant / Advisor | 01.10.2019 |
Ehemalige bekannte Positionen von D. Ackermann
Unternehmen | Position | Ende |
---|---|---|
TARSUS PHARMACEUTICALS, INC. | Founder | 02.12.2022 |
OYSR POIN | Founder | 08.10.2020 |
ALLERGAN, INC. | Corporate Officer/Principal | 01.06.2017 |
Oculeve, Inc.
Oculeve, Inc. Medical SpecialtiesHealth Technology Oculeve, Inc. develops devices for dry eye disease treatment. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Garrett Cale Smith and Victor Wayne McCray in 2011 and is headquartered in Parsippany, NJ. | Chief Executive Officer | 11.08.2015 |
Tangible Science, Inc.
Tangible Science, Inc. Medical SpecialtiesHealth Technology Tangible Science, Inc. manufactures contact lenses and provides eye care services. It develops a novel polymer based coating technology for use in contact lenses to treat dry eye disease. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Karen Havenstrite, Victor W. McCray, and Garrett Cale Smith in 2011 and is headquartered in Redwood City, CA. | Founder | - |
Ausbildung von D. Ackermann
Vanderbilt University | Undergraduate Degree |
Case Western Reserve University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TARSUS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Oculeve, Inc.
Oculeve, Inc. Medical SpecialtiesHealth Technology Oculeve, Inc. develops devices for dry eye disease treatment. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Garrett Cale Smith and Victor Wayne McCray in 2011 and is headquartered in Parsippany, NJ. | Health Technology |
Tangible Science, Inc.
Tangible Science, Inc. Medical SpecialtiesHealth Technology Tangible Science, Inc. manufactures contact lenses and provides eye care services. It develops a novel polymer based coating technology for use in contact lenses to treat dry eye disease. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Karen Havenstrite, Victor W. McCray, and Garrett Cale Smith in 2011 and is headquartered in Redwood City, CA. | Health Technology |
Oyster Point Pharma, Inc.
Oyster Point Pharma, Inc. Pharmaceuticals: MajorHealth Technology Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ. | Health Technology |
Vensana Capital Management LLC
Vensana Capital Management LLC Investment ManagersFinance Vensana Capital Management LLC (Vensana Capital) is a venture capital and growth equity investment firm founded in 2019 by Peter Klein Justin & Kirk G. Nielsen. The firm is headquartered in Saint Paul, Minnesota. | Finance |
Presidio Medical, Inc.
Presidio Medical, Inc. Medical SpecialtiesHealth Technology Presidio Medical, Inc. operates as a bioelectronic medicine firm. It develops fundamental neuromodulation platform to establish a new class of therapeutic medical devices. The company was founded by Kenneth Wu on November 14, 2018 and is headquartered in Carson City, NV. | Health Technology |
Stanford Byers Center for Biodesign
Stanford Byers Center for Biodesign Miscellaneous Commercial ServicesCommercial Services Stanford Byers Center for Biodesign is a private company committed to advancing health outcomes and equity through innovation education, translation, and policy. More than 4.3 million people have been helped by technologies invented at Stanford Biodesign, and the biodesign innovation process has been widely adopted by universities and training programs around the world. The American company believes that diversity across multiple dimensions inspires creativity and helps them innovate for all patient populations. The company was founded by Joshua Makower and Paul G. Yock in 2001 at Stanford. | Commercial Services |